Tuesday, October 4, 2022
Home Tags Dupilumab

Tag: dupilumab

Regeneron dermatitis drug Dupixent approved in Japan

The antibody drug was approved for use in the U,S. last March.

Regeneron dermatitis drug approved for European market

The antibody drug will be marketed as Dupixent and available to adults with moderate to severe atopic dermatitis .

FDA approves new Regeneron drug treating severe eczema

Dupixent will go on the U.S. market this week as the first antibody medicine for uncontrolled itching and rashes in adults with atopic dermatitis.